CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dongwha Pharm Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dongwha Pharm Co Ltd
19F, 98, Huam-Ro, Jung-Gu
Phone: +82 220219300p:+82 220219300 SEOUL, 04522  South Korea Ticker: 000020000020
Business Summary
Dongwha Pharm Co Ltd is a Korea-based company primarily engaged in the manufacture of pharmaceuticals. The Company operates its business through four segments. The Pharmaceutical segment mainly manufactures and sells medicinal products including Huomingsu medicines, Fusidin medicines, Pancold medicines, Itch medicines, circulatory and diabetes medicines, as well as digestive medicines. The Pharmaceutical Distribution Chain segment mainly operates overseas pharmaceutical distribution business. The Medical Device segment mainly provides products such as orthopedic implants. The Other segment mainly operates real estate rental business. In addition, the Company also manufactures and sells health functional food products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
3842 Orthopedic, prosthetic, and surgical appliances and supplies
5122 Drugs, drug proprietaries, and druggists' sundries
6512 Operators of nonresidential buildings
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman Do JunYoon 74 3/21/2019 5/27/2005
Chief Executive Officer, Director Jun HaYoo 61 3/31/2023 3/15/2021
Vice Chairman Gil JunYoon 68 1/1/2009 2/1/2008
10 additional Officers and Directors records available in full report.

Business Names
Business Name
000020
Dongwha Pharm Ind Co., Ltd.
Dongwha Pharmaceutical Industry Co.
Trung Son Pharma

General Information
Number of Employees: 723 (As of 9/30/2018)
Outstanding Shares: 27,717,930 (As of 12/31/2025)
Shareholders: 25,236
Stock Exchange: KRX
Fax Number: +82 220219427


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 11, 2026